Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Recruiting 3Withdrawn 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Prostatic Neoplasms 11Leukemia, Myeloid, Acute 10Lung Neoplasms 9Myelodysplastic Syndromes 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasm Metastasis 5Multiple Myeloma 5Leukemia, Myelomonocytic, Chronic 5Carcinoma, Non-Small-Cell Lung 5Leukemia, Biphenotypic, Acute 4Colorectal Neoplasms 4Carcinoma, Hepatocellular 4Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Rectal Neoplasms 3Pancreatic Neoplasms 3Osteosarcoma 3Mouth Neoplasms 3Lymphoma, T-Cell 3Lymphoma, Non-Hodgkin 3Lymphoma, Large B-Cell, Diffuse 3Endometrial Neoplasms 3Carcinoma, Renal Cell 3Wilms Tumor 2Thyroid Cancer, Papillary 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Myeloproliferative Disorders 2Mycosis Fungoides 2Melanoma 2

Interventions

Magnetic Resonance Spectroscopy 11Specimen Handling 9Cisplatin 8Radiation 6pembrolizumab 5Platinum 5Biopsy 51,2-diaminocyclohexaneplatinum II citrate 5Sentinel Lymph Node Biopsy 4Radiotherapy 4Drug Therapy 4cemiplimab 3X-Rays 3Ultrasonography 3Standard of Care 3Radiotherapy, Intensity-Modulated 3Cetuximab 3Carboplatin 3Taxes 2Surgical Procedures, Operative 2Practice Guidelines as Topic 2Photons 2Paclitaxel 2Interviews as Topic 2trastuzumab deruxtecan 1toripalimab 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1sacituzumab govitecan 1niraparib 1merphos 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Mouth Neoplasms × X-Rays × Clear all
NCT06997068 2026-05-11

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

Mayo Clinic

Phase 2 Recruiting
25 enrolled
Head & Neck

Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT04333537 2026-05-04

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

NRG Oncology

Phase 2/3 Recruiting
686 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT07121595 2025-08-13

Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial

University of Michigan Rogel Cancer Center

Phase 2 Recruiting
50 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡